Top Story

Percutaneous mitral valve implantation effective in patients with failed mitral bioprosthesis

May 27, 2016
In high-risk patients with degenerated mitral bioprosthesis, percutaneous antegrade transvenous mitral valve implantation appears to be a minimally invasive and highly effective strategy that has been linked with rapid hemodynamic improvement, short length of hospital stays and improved functional status. 

Researchers conducted a retrospective study of 48 patients who underwent percutaneous transfemoral antegrade transseptal implantation of the Sapien, Sapien XT or Sapien 3 valves (Edwards Lifesciences) into the mitral position at Mayo Clinic; New York University Medical Center; Intermountain Heart Institute in Birmingham, Alabama, or St. Michael’s Hospital in Toronto from 2014 to 2015.

In the Journals

Preoperative anemia increases mortality risk after surgery for CLI

May 27, 2016
Patients with critical limb ischemia are at greater immediate- and long-term risk for death after surgery if they have anemia before undergoing treatment, according to…
Meeting News Coverage

Flu vaccination may reduce dementia risk in patients with HF

May 27, 2016
Patients with HF who receive the influenza vaccination have a 35% reduced risk for dementia, according to new data presented at Heart Failure 2016 and the 3rd World…

Disputed meta-analysis finds low sodium intake may increase CV risk, mortality

May 27, 2016
A low-sodium diet may increase the risk for CV events and mortality in adults with and without hypertension, researchers reported in The Lancet.The systematic review…
FDA News

FDA rejects hyperkalemia treatment due to manufacturing issue

May 27, 2016
AstraZeneca announced that it received a complete response letter from the FDA indicating that sodium zirconium cyclosilicate will not be approved at this time due to…
More News Headlines »